Showing results (1341-1350 of 1,764) with videos related to

Sort By:
Pageof 177
Oncotarget|September 8, 2016
ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapyFei Ma, Wenjie Zhu, Yanfang Guan, et al.
American Journal of Nephrology|November 20, 2009
The modifier protein of glyceraldehyde-3-phosphate dehydrogenase reduces free radical-mediated renal damage in a rat model of acute kidney injuryZi-Long Li, Ying-Hui Sun, Qiu-Ling Fan, et al.
Annals of Translational Medicine|January 14, 2020
Lactate dehydrogenase as a prognostic marker of renal transplant recipients with severe community-acquired pneumonia: a 10-year retrospective studyYing Su, Min-Jie Ju, Jie-Fei Ma, et al.
Journal of Advanced Research|October 31, 2025
Functional divergence of BnaWRKY7 homologs drives phytosterol variations in polyploid Brassica napusXueyan Wang, Xuan Tian, Xiong Zhang, et al.
Oncotarget|October 4, 2014
A central role for TRPS1 in the control of cell cycle and cancer developmentLele Wu, Yuzhi Wang, Yan Liu, et al.
Acta Pharmacologica Sinica|January 29, 2021
Widespread myocardial dysfunction in COVID-19 patients detected by myocardial strain imaging using 2-D speckle-tracking echocardiographyRui Li, Hong Wang, Fei Ma, et al.
Genes & Genomics|November 12, 2021
RPTOR methylation in the peripheral blood and breast cancer in the Chinese populationYifei Yin, Shuifang Lei, Lixi Li, et al.
Gene|February 12, 2023
Genome-wide identification and skin expression of immunoglobulin superfamily in discus fish (Symphysodon aequifasciatus) reveal common genes associated with vertebrate lactationXin Liu, Xiang-Fei Ding, Bin Wen, et al.
Biomarker Research|February 21, 2023
Survival benefit and biomarker analysis of pyrotinib or pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer: a pooled analysis of two phase I studiesXiuwen Guan, Fei Ma, Qiao Li, et al.
Clinical Breast Cancer|February 7, 2021
Primary Trastuzumab Resistance After (Neo)adjuvant Trastuzumab-containing Treatment for Patients With HER2-positive Breast Cancer in Real-world PracticeXuelian Chen, Jiayu Wang, Ying Fan, et al.
Pageof 177